AOP Orphan Pharmaceuticals AG, Tetrabenazine 25 mg tablets, PL 21344/0015
Yes – this has been recalled
- The problem
- AOP Orphan Pharmaceuticals AG is recalling all unexpired stock of a batch of Tetrabenazine 25 mg tablets (from pharmacies and wholesalers) as a precautionary measure due to out of specification results for the assay, obtained during routine stability testing.
- What to do
- Check the batch number on your pack against the list below. Do not stop taking a prescribed medicine without talking to your pharmacist, GP or prescriber first – they can check your supply and swap it if needed.
Source: Medicines and Healthcare products Regulatory Agency (MHRA)
Official notice ↗
MDR Number
MDR 194-02/20
Company name
AOP Orphan Pharmaceuticals AG
Product description
Tetrabenazine 25 mg tablets PL 21344/0015
- Batch Number: T1704UK
- Expiry Date: 09/2020
- Pack Size: 112
- First Distributed: 31/12/2017
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Company contacts for further information
For more information or medical information queries, please contact medinfo@aoporphan.com.
For stock control queries, please contact orderservice@aoporphan.com.
Recipients should bring it to the attention of relevant contacts by copy of this letter.
NHS Regional teams are asked to forward this to relevant clinics, general practitioners and community pharmacists.
Download document
Updated 2 March 2020. This page summarises an official notice. Details can change – always follow the official notice.